Angiotensin 2 Receptor Blocker [EPC]

Angiotensin 2 Receptor Blocker [EPC] was reported 319976 times

Drugs of the Angiotensin 2 Receptor Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 NEUROLOGIC NEGLECT SYNDROME 305 0.5486
1 THROAT CLEARING 1580 0.4211
2 CAROTID ARTERY THROMBOSIS 320 0.3769
3 EJECTION FRACTION ABNORMAL 462 0.3768
4 ADJUSTMENT DISORDER 324 0.2492
5 AMAUROSIS FUGAX 260 0.2414
6 BLOOD PRESSURE INADEQUATELY CONTROLLED 1452 0.2411
7 CARDIAC FAILURE CHRONIC 841 0.1971
8 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 276 0.1964
9 EJECTION FRACTION DECREASED 2845 0.1829
10 CARDIAC DYSFUNCTION 575 0.1544
11 BLOOD POTASSIUM INCREASED 2195 0.1351
12 NEPHROGENIC ANAEMIA 622 0.1341
13 PHYSICAL DECONDITIONING 345 0.1339
14 INFARCTION 907 0.1324
15 HYPERPARATHYROIDISM SECONDARY 324 0.1292
16 PERSONALITY DISORDER 335 0.1278
17 BLOOD PRESSURE SYSTOLIC DECREASED 577 0.1267
18 BLOOD PRESSURE SYSTOLIC ABNORMAL 311 0.1257
19 WEIGHT FLUCTUATION 1263 0.1206
20 CONCOMITANT DISEASE AGGRAVATED 723 0.1170
21 BRAIN NATRIURETIC PEPTIDE INCREASED 353 0.1144
22 ORTHOPNOEA 359 0.1126
23 BLOOD PRESSURE DIASTOLIC ABNORMAL 278 0.1092
24 ISCHAEMIC CARDIOMYOPATHY 324 0.1056
25 DIZZINESS POSTURAL 1018 0.1049
26 BUNDLE BRANCH BLOCK LEFT 436 0.1027
27 GLOMERULAR FILTRATION RATE DECREASED 1194 0.0971
28 DIASTOLIC DYSFUNCTION 294 0.0951
29 FEAR OF DISEASE 168 0.0944
30 OLIGOHYDRAMNIOS 310 0.0929
31 BLOOD PRESSURE DIASTOLIC DECREASED 684 0.0926
32 PRESCRIBED UNDERDOSE 1843 0.0923
33 MACULAR DEGENERATION 1099 0.0919
34 HYPERKALAEMIA 3227 0.0919
35 HEART VALVE INCOMPETENCE 262 0.0914
36 LEFT VENTRICULAR HYPERTROPHY 387 0.0903
37 BLOOD PRESSURE SYSTOLIC INCREASED 1759 0.0901
38 HYPOTENSION 18046 0.0899
39 BLOOD PRESSURE FLUCTUATION 2146 0.0893
40 ARTERIAL OCCLUSIVE DISEASE 688 0.0874
41 BLOOD PRESSURE DECREASED 5812 0.0874
42 MITRAL VALVE INCOMPETENCE 964 0.0851
43 CARDIAC FAILURE 6727 0.0837
44 MULTI-ORGAN DISORDER 163 0.0828
45 VENTRICULAR HYPOKINESIA 255 0.0793
46 CHRONIC SINUSITIS 295 0.0785
47 RADICULOPATHY 207 0.0785
48 BLOOD PRESSURE ABNORMAL 1553 0.0780
49 HEMIPLEGIA 640 0.0769
50 AORTIC VALVE INCOMPETENCE 327 0.0768
51 CARDIOMEGALY 938 0.0762
52 TRICUSPID VALVE INCOMPETENCE 591 0.0743
53 BLOOD SODIUM INCREASED 199 0.0737
54 LEFT VENTRICULAR DYSFUNCTION 490 0.0731
55 CARDIAC FAILURE ACUTE 476 0.0714
56 TACHYARRHYTHMIA 178 0.0713
57 URINARY TRACT DISORDER 320 0.0710
58 BLOOD POTASSIUM ABNORMAL 189 0.0708
59 BLOOD URIC ACID INCREASED 408 0.0706
60 AORTIC ARTERIOSCLEROSIS 180 0.0699
61 HYPERTENSIVE CRISIS 773 0.0694
62 BLOOD UREA INCREASED 1162 0.0693
63 DECREASED ACTIVITY 748 0.0693
64 HYPOACUSIS 2946 0.0684
65 EXERCISE TOLERANCE DECREASED 393 0.0682
66 CONGESTIVE CARDIOMYOPATHY 282 0.0676
67 FLUID RETENTION 3344 0.0657
68 BLOOD PRESSURE INCREASED 9950 0.0650
69 REBOUND ACID HYPERSECRETION 196 0.0647
70 HEART RATE DECREASED 2260 0.0643
71 HAEMORRHAGIC STROKE 502 0.0642
72 CORONARY ARTERY STENOSIS 322 0.0640
73 HYPERURICAEMIA 262 0.0637
74 RENAL CYST 506 0.0636
75 DIVERTICULUM INTESTINAL 278 0.0635
76 CAROTID ARTERY STENOSIS 222 0.0635
77 BREATH SOUNDS ABNORMAL 313 0.0634
78 VENTRICULAR EXTRASYSTOLES 654 0.0629
79 GOUT 1127 0.0627
80 ANGINA PECTORIS 1761 0.0614
81 LEFT VENTRICULAR FAILURE 211 0.0612
82 BLOOD CREATINE INCREASED 268 0.0605
83 PROTEIN URINE PRESENT 300 0.0601
84 DYSPNOEA AT REST 174 0.0600
85 VENTRICULAR ARRHYTHMIA 219 0.0598
86 RALES 346 0.0595
87 BLOOD SODIUM DECREASED 1108 0.0587
88 AORTIC STENOSIS 204 0.0585
89 BLOOD CREATININE INCREASED 3783 0.0579
90 ATRIOVENTRICULAR BLOCK 447 0.0578
91 SENSORY LOSS 465 0.0577
92 HYPONATRAEMIA 3248 0.0576
93 PULMONARY PAIN 168 0.0575
94 RENAL FAILURE CHRONIC 433 0.0563
95 ATRIAL FLUTTER 446 0.0558
96 ARTERIOSCLEROSIS CORONARY ARTERY 369 0.0556
97 BLOOD PRESSURE DIASTOLIC INCREASED 256 0.0554
98 END STAGE RENAL DISEASE 1008 0.0552
99 HEART RATE ABNORMAL 304 0.0545
100 PRODUCT PRESCRIBING ERROR 1295 0.0543
101 ACUTE KIDNEY INJURY 8306 0.0542
102 GANGRENE 327 0.0542
103 COLITIS MICROSCOPIC 257 0.0542
104 NEAR DEATH EXPERIENCE 179 0.0542
105 ANGINA UNSTABLE 351 0.0540
106 ARTERIOSCLEROSIS 506 0.0537
107 RENAL FUNCTION TEST ABNORMAL 249 0.0536
108 DIABETIC NEUROPATHY 265 0.0535
109 DIABETES MELLITUS 4077 0.0534
110 DYSPNOEA EXERTIONAL 2007 0.0532
111 ORTHOSTATIC HYPOTENSION 922 0.0529
112 ARRHYTHMIA 2501 0.0528
113 HYPOVOLAEMIA 307 0.0524
114 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 213 0.0521
115 CARDIAC VALVE DISEASE 298 0.0521
116 ATRIAL FIBRILLATION 5066 0.0520
117 VENTRICULAR TACHYCARDIA 854 0.0517
118 RENAL IMPAIRMENT 4336 0.0516
119 CARDIOMYOPATHY 758 0.0512
120 HYPERTENSION 10850 0.0512
121 GLUCOSE TOLERANCE IMPAIRED 302 0.0510
122 SLEEP APNOEA SYNDROME 973 0.0509
123 CONTRAINDICATED PRODUCT ADMINISTERED 1541 0.0508
124 DYSLIPIDAEMIA 258 0.0507
125 IRON DEFICIENCY 228 0.0506
126 SUPRAVENTRICULAR EXTRASYSTOLES 171 0.0506
127 BENIGN PROSTATIC HYPERPLASIA 260 0.0503
128 HIGH DENSITY LIPOPROTEIN DECREASED 167 0.0501
129 CORONARY ARTERY DISEASE 1516 0.0500
130 GENERALISED OEDEMA 618 0.0499
131 COUGH 13972 0.0498
132 ATRIOVENTRICULAR BLOCK COMPLETE 333 0.0497
133 CORONARY ARTERY OCCLUSION 680 0.0495
134 ANURIA 423 0.0491
135 PULMONARY OEDEMA 2165 0.0483
136 HEPATIC CYST 164 0.0482
137 ATRIOVENTRICULAR BLOCK FIRST DEGREE 208 0.0479
138 RENAL DISORDER 2221 0.0476
139 URINE ABNORMALITY 216 0.0475
140 OLIGURIA 294 0.0473
141 ERYSIPELAS 237 0.0471
142 MAJOR DEPRESSION 343 0.0469
143 OVERWEIGHT 252 0.0469
144 SPINAL OSTEOARTHRITIS 412 0.0469
145 HEART RATE IRREGULAR 1059 0.0468
146 CARDIAC FAILURE CONGESTIVE 3761 0.0468
147 PEMPHIGOID 353 0.0467
148 THYROID DISORDER 716 0.0464
149 POLLAKIURIA 1934 0.0463
150 URINE OUTPUT DECREASED 404 0.0462
151 NOCTURIA 559 0.0460
152 PERIPHERAL VASCULAR DISORDER 236 0.0458
153 CHRONIC KIDNEY DISEASE 3473 0.0457
154 CARDIAC FLUTTER 295 0.0456
155 CAROTID ARTERY OCCLUSION 166 0.0455
156 VARICOSE VEIN 234 0.0453
157 POLYURIA 369 0.0450
158 HYPERLIPIDAEMIA 538 0.0450
159 MYOCARDIAL ISCHAEMIA 511 0.0449
160 POOR PERIPHERAL CIRCULATION 191 0.0448
161 PRESYNCOPE 1089 0.0447
162 DEAFNESS 1170 0.0447
163 GOITRE 183 0.0446
164 CARDIAC DISORDER 4162 0.0444
165 BLOOD CHOLESTEROL ABNORMAL 205 0.0443
166 ACUTE PULMONARY OEDEMA 249 0.0443
167 HEAD DISCOMFORT 784 0.0442
168 EXTRASYSTOLES 309 0.0442
169 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8918 0.0440
170 AZOTAEMIA 175 0.0438
171 OEDEMA PERIPHERAL 5293 0.0434
172 ANEURYSM 216 0.0433
173 AORTIC ANEURYSM 330 0.0433
174 HIATUS HERNIA 560 0.0432
175 HYPERVOLAEMIA 212 0.0429
176 CEREBRAL INFARCTION 1046 0.0428
177 GASTRITIS EROSIVE 197 0.0422
178 RENAL FAILURE 5604 0.0422
179 DIVERTICULUM 299 0.0420
180 MOTOR DYSFUNCTION 428 0.0420
181 CREATININE RENAL CLEARANCE DECREASED 167 0.0417
182 AFFECT LABILITY 398 0.0413
183 CARDIOGENIC SHOCK 593 0.0413
184 CATHETERISATION CARDIAC 183 0.0412
185 ACUTE MYOCARDIAL INFARCTION 1216 0.0412
186 IRON DEFICIENCY ANAEMIA 379 0.0410
187 HAEMORRHAGIC ANAEMIA 180 0.0409
188 DIABETES MELLITUS INADEQUATE CONTROL 723 0.0408
189 CEREBRAL ISCHAEMIA 210 0.0408
190 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 419 0.0408
191 BLOOD POTASSIUM DECREASED 1224 0.0407
192 INGUINAL HERNIA 247 0.0406
193 SYNCOPE 4060 0.0405
194 GLAUCOMA 778 0.0404
195 ISCHAEMIA 185 0.0402
196 RED CELL DISTRIBUTION WIDTH INCREASED 167 0.0402
197 HEMIPARESIS 678 0.0400
198 HYPOMAGNESAEMIA 556 0.0399
199 SINUS CONGESTION 538 0.0398
200 DIZZINESS 19857 0.0398
201 SINUS BRADYCARDIA 382 0.0395
202 INFLAMMATORY MARKER INCREASED 195 0.0393
203 LACTIC ACIDOSIS 1272 0.0392
204 HYPOKINESIA 566 0.0389
205 CARDIAC PACEMAKER INSERTION 232 0.0389
206 OBSTRUCTIVE AIRWAYS DISORDER 432 0.0388
207 ENERGY INCREASED 229 0.0388
208 MUSCLE SPASTICITY 476 0.0387
209 PROTEINURIA 732 0.0385
210 PULMONARY CONGESTION 507 0.0384
211 CARDIAC MURMUR 330 0.0381
212 HYPERCHOLESTEROLAEMIA 368 0.0381
213 HYPOKALAEMIA 1758 0.0380
214 RENAL FAILURE ACUTE 1616 0.0380
215 PERICARDIAL EFFUSION 880 0.0380
216 ALTERED STATE OF CONSCIOUSNESS 822 0.0379
217 EYE HAEMORRHAGE 504 0.0377
218 BRADYCARDIA 2003 0.0377
219 WEIGHT DECREASED 10541 0.0377
220 OBESITY 595 0.0373
221 OSTEOARTHRITIS 1583 0.0373
222 MUSCULOSKELETAL DISCOMFORT 642 0.0373
223 SEASONAL ALLERGY 524 0.0370
224 VENTRICULAR FIBRILLATION 411 0.0370
225 RENAL PAIN 392 0.0369
226 BODY TEMPERATURE DECREASED 362 0.0367
227 COORDINATION ABNORMAL 511 0.0366
228 BUNDLE BRANCH BLOCK RIGHT 168 0.0366
229 METABOLIC ACIDOSIS 1169 0.0365
230 SUDDEN DEATH 384 0.0363
231 ELECTROCARDIOGRAM ABNORMAL 283 0.0360
232 BLOOD MAGNESIUM DECREASED 311 0.0360
233 SNEEZING 807 0.0359
234 RED BLOOD CELL SEDIMENTATION RATE INCREASED 397 0.0358
235 PERIPHERAL SWELLING 5525 0.0358
236 UPPER-AIRWAY COUGH SYNDROME 295 0.0358
237 MYOCARDIAL INFARCTION 6233 0.0357
238 OCULAR DISCOMFORT 398 0.0354
239 SHOCK HAEMORRHAGIC 288 0.0353
240 HYPOVOLAEMIC SHOCK 169 0.0352
241 MUSCLE STRAIN 305 0.0352
242 NEPHROPATHY 327 0.0350
243 HEPATIC STEATOSIS 652 0.0350
244 BLOOD TRIGLYCERIDES INCREASED 618 0.0349
245 ANGIOEDEMA 1543 0.0348
246 EATING DISORDER 739 0.0347
247 CEREBROVASCULAR ACCIDENT 5879 0.0347
248 ASPHYXIA 283 0.0346
249 DRUG PRESCRIBING ERROR 665 0.0346
250 RECALLED PRODUCT ADMINISTERED 329 0.0345
251 RENAL TUBULAR NECROSIS 338 0.0344
252 ANGIOPATHY 193 0.0344
253 GASTRITIS 903 0.0343
254 PRODUCTIVE COUGH 1638 0.0343
255 HAEMATURIA 1172 0.0342
256 SINUS DISORDER 677 0.0342
257 JOINT DISLOCATION 361 0.0341
258 HAEMATOCRIT DECREASED 677 0.0341
259 APHASIA 1028 0.0340
260 OEDEMA 1845 0.0340
261 LOW DENSITY LIPOPROTEIN INCREASED 263 0.0339
262 CATARACT 2022 0.0339
263 VEIN DISORDER 169 0.0337
264 GLYCOSYLATED HAEMOGLOBIN INCREASED 848 0.0336
265 LARGE INTESTINE POLYP 232 0.0335
266 ACUTE CORONARY SYNDROME 277 0.0334
267 DYSPNOEA 18918 0.0334
268 HYPOGLYCAEMIA 1619 0.0333
269 SLUGGISHNESS 340 0.0333
270 LIMB DISCOMFORT 1031 0.0333
271 ELECTROLYTE IMBALANCE 387 0.0333
272 TUBULOINTERSTITIAL NEPHRITIS 624 0.0333
273 INTERVERTEBRAL DISC DEGENERATION 307 0.0331
274 LYMPHOEDEMA 228 0.0329
275 DEMENTIA 921 0.0329
276 ARTHRITIS 2584 0.0328
277 PRODUCT ADMINISTRATION ERROR 662 0.0327
278 PERIPHERAL COLDNESS 449 0.0327
279 DEHYDRATION 4361 0.0327
280 SPUTUM DISCOLOURED 309 0.0325
281 HEART RATE INCREASED 3223 0.0325
282 GASTROENTERITIS 474 0.0324
283 BLOOD CHOLESTEROL INCREASED 1513 0.0324
284 DUODENAL ULCER 228 0.0323
285 RHINORRHOEA 2079 0.0321
286 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1675 0.0321
287 RHINITIS 258 0.0320
288 FALL 10649 0.0320
289 MELAENA 704 0.0320
290 ISCHAEMIC STROKE 568 0.0318
291 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 281 0.0318
292 LIMB INJURY 862 0.0317
293 RESPIRATORY TRACT CONGESTION 501 0.0315
294 RHABDOMYOLYSIS 1312 0.0314
295 SHOCK 722 0.0314
296 ATELECTASIS 303 0.0313
297 MEMORY IMPAIRMENT 4303 0.0313
298 SCIATICA 499 0.0313
299 BASAL CELL CARCINOMA 485 0.0311
300 C-REACTIVE PROTEIN INCREASED 1131 0.0311
301 NEPHROTIC SYNDROME 213 0.0310
302 WEIGHT INCREASED 6945 0.0310
303 CHEST PAIN 5740 0.0310
304 DRY THROAT 314 0.0309
305 TROPONIN INCREASED 235 0.0309
306 BLOOD GLUCOSE FLUCTUATION 337 0.0307
307 GASTRIC ULCER HAEMORRHAGE 170 0.0306
308 DYSURIA 1129 0.0306
309 MENISCUS INJURY 188 0.0305
310 DIVERTICULITIS 845 0.0305
311 PULMONARY HYPERTENSION 629 0.0302
312 RESPIRATORY RATE INCREASED 268 0.0302
313 HAEMORRHOIDS 586 0.0300
314 CHEST DISCOMFORT 3075 0.0300
315 BRONCHITIS 2217 0.0299
316 PARAESTHESIA ORAL 432 0.0299
317 EMPHYSEMA 302 0.0299
318 DRUG INTERACTION 4746 0.0299
319 ASTHENIA 11185 0.0297
320 UPPER GASTROINTESTINAL HAEMORRHAGE 499 0.0296
321 FEAR 797 0.0296
322 RESPIRATION ABNORMAL 204 0.0296
323 MALNUTRITION 331 0.0296
324 COLON CANCER 440 0.0295
325 FLANK PAIN 276 0.0294
326 SKIN HAEMORRHAGE 434 0.0293
327 PROTHROMBIN TIME PROLONGED 175 0.0292
328 HAEMATEMESIS 737 0.0290
329 BLOOD URINE PRESENT 550 0.0289
330 TRANSIENT ISCHAEMIC ATTACK 975 0.0289
331 MICTURITION URGENCY 330 0.0289
332 JOINT INJURY 616 0.0288
333 GAMMA-GLUTAMYLTRANSFERASE INCREASED 639 0.0288
334 TYPE 2 DIABETES MELLITUS 970 0.0288
335 SPEECH DISORDER 1507 0.0287
336 DYSSTASIA 839 0.0287
337 HAEMATOMA 743 0.0286
338 CIRCULATORY COLLAPSE 488 0.0286
339 BLOOD CREATINE PHOSPHOKINASE INCREASED 824 0.0286
340 NERVOUSNESS 1493 0.0285
341 RIB FRACTURE 587 0.0285
342 BLINDNESS 1162 0.0285
343 HYPERGLYCAEMIA 1034 0.0283
344 PLEURAL EFFUSION 1718 0.0282
345 BLOOD IRON DECREASED 335 0.0282
346 SUPRAVENTRICULAR TACHYCARDIA 270 0.0282
347 OROPHARYNGEAL DISCOMFORT 254 0.0281
348 HYPERCALCAEMIA 346 0.0280
349 POSTOPERATIVE WOUND INFECTION 189 0.0280
350 RENAL INJURY 831 0.0279
351 CARDIO-RESPIRATORY ARREST 1165 0.0278
352 PALPITATIONS 3261 0.0278
353 ANKLE FRACTURE 430 0.0278
354 HYPOTHYROIDISM 884 0.0277
355 ROTATOR CUFF SYNDROME 355 0.0276
356 EOSINOPHILIA 484 0.0276
357 ORAL CANDIDIASIS 363 0.0275
358 LOSS OF CONSCIOUSNESS 3529 0.0275
359 OXYGEN SATURATION DECREASED 1546 0.0275
360 LIGAMENT SPRAIN 272 0.0275
361 BODY HEIGHT DECREASED 294 0.0275
362 VITAMIN D DEFICIENCY 268 0.0275
363 CYSTITIS 875 0.0275
364 SPINAL DISORDER 260 0.0274
365 ASCITES 807 0.0274
366 GAIT DISTURBANCE 5239 0.0273
367 URINARY RETENTION 913 0.0273
368 MALAISE 11946 0.0272
369 FAECES SOFT 198 0.0272
370 DYSPHONIA 1588 0.0271
371 HEAD INJURY 857 0.0271
372 PANCREATITIS ACUTE 607 0.0270
373 FEELING ABNORMAL 6460 0.0269
374 PULMONARY FIBROSIS 517 0.0269
375 DYSARTHRIA 1010 0.0268
376 SUBDURAL HAEMATOMA 384 0.0268
377 SCOLIOSIS 166 0.0268
378 PULMONARY MASS 399 0.0268
379 MOVEMENT DISORDER 860 0.0268
380 TINNITUS 1224 0.0266
381 CHOLESTASIS 511 0.0266
382 JOINT SWELLING 3207 0.0265
383 THIRST 474 0.0265
384 CHOKING 517 0.0265
385 FAECES DISCOLOURED 573 0.0264
386 FATIGUE 20512 0.0263
387 NERVE COMPRESSION 243 0.0263
388 BLOOD CALCIUM DECREASED 296 0.0263
389 ACCIDENT 314 0.0263
390 POLYNEUROPATHY 313 0.0261
391 UROSEPSIS 241 0.0261
392 VERTIGO 1592 0.0261
393 POLYP 171 0.0261
394 SPINAL PAIN 306 0.0261
395 ECCHYMOSIS 179 0.0261
396 INTERVERTEBRAL DISC PROTRUSION 570 0.0260
397 BACK DISORDER 423 0.0260
398 SWELLING 2428 0.0259
399 BLOOD GLUCOSE ABNORMAL 478 0.0259
400 INTERNATIONAL NORMALISED RATIO INCREASED 737 0.0258
401 CARPAL TUNNEL SYNDROME 362 0.0258
402 GAIT INABILITY 863 0.0258
403 GENERAL PHYSICAL HEALTH DETERIORATION 2982 0.0257
404 ANAEMIA 4895 0.0256
405 BLOOD ALBUMIN DECREASED 203 0.0256
406 LIPASE INCREASED 196 0.0256
407 MUSCULAR WEAKNESS 2897 0.0255
408 PROSTATIC SPECIFIC ANTIGEN INCREASED 350 0.0254
409 DRUG INTOLERANCE 2454 0.0254
410 INTERSTITIAL LUNG DISEASE 1227 0.0253
411 EOSINOPHIL COUNT INCREASED 211 0.0253
412 URINARY INCONTINENCE 750 0.0253
413 ENTERITIS 162 0.0253
414 PELVIC FRACTURE 197 0.0253
415 HYPERTHYROIDISM 365 0.0252
416 CHOLELITHIASIS 826 0.0252
417 NASOPHARYNGITIS 4638 0.0251
418 GASTROOESOPHAGEAL REFLUX DISEASE 2019 0.0251
419 BURSITIS 303 0.0249
420 GASTRIC ULCER 474 0.0249
421 POOR QUALITY SLEEP 532 0.0247
422 RED BLOOD CELL COUNT DECREASED 706 0.0247
423 ILLNESS 2538 0.0246
424 BLOOD LACTATE DEHYDROGENASE INCREASED 390 0.0246
425 DIPLOPIA 639 0.0246
426 GROIN PAIN 216 0.0246
427 STENT PLACEMENT 197 0.0244
428 SWOLLEN TONGUE 763 0.0244
429 DYSPEPSIA 2402 0.0244
430 HAEMATOCHEZIA 1346 0.0244
431 APHONIA 339 0.0243
432 BLOOD CALCIUM INCREASED 213 0.0243
433 BLOOD GLUCOSE DECREASED 1165 0.0242
434 FRUSTRATION TOLERANCE DECREASED 196 0.0242
435 WHEEZING 1438 0.0242
436 HIP FRACTURE 779 0.0242
437 INCONTINENCE 256 0.0242
438 SKIN LACERATION 263 0.0242
439 HAEMODIALYSIS 202 0.0240
440 HAEMOGLOBIN DECREASED 2463 0.0240
441 SKIN ULCER 620 0.0240
442 EXOSTOSIS 219 0.0240
443 ANOREXIA 309 0.0240
444 SYNOVITIS 431 0.0239
445 BALANCE DISORDER 2066 0.0239
446 NASAL CONGESTION 1404 0.0239
447 UPPER LIMB FRACTURE 475 0.0238
448 CHOLECYSTITIS 284 0.0238
449 TOXIC SKIN ERUPTION 240 0.0238
450 LOWER GASTROINTESTINAL HAEMORRHAGE 176 0.0238
451 MUSCULOSKELETAL CHEST PAIN 368 0.0238
452 AMNESIA 1545 0.0237
453 HYPOCALCAEMIA 448 0.0236
454 ERECTILE DYSFUNCTION 606 0.0236
455 EAR DISCOMFORT 242 0.0236
456 SUBARACHNOID HAEMORRHAGE 240 0.0235
457 CARDIAC ARREST 1945 0.0235
458 CONTUSION 2267 0.0235
459 METASTASES TO LUNG 272 0.0235
460 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4239 0.0235
461 DECREASED APPETITE 5453 0.0235
462 RECTAL HAEMORRHAGE 1008 0.0234
463 QUALITY OF LIFE DECREASED 314 0.0234
464 PRURITUS GENERALISED 506 0.0234
465 VISUAL IMPAIRMENT 2899 0.0234
466 BLOOD GLUCOSE INCREASED 4402 0.0233
467 MYALGIA 3964 0.0233
468 ARTHROPATHY 1294 0.0233
469 CEREBRAL HAEMORRHAGE 833 0.0232
470 SEROTONIN SYNDROME 446 0.0232
471 ULCER 368 0.0231
472 SLEEP DISORDER 1630 0.0231
473 BACK INJURY 251 0.0231
474 HEPATIC CYTOLYSIS 294 0.0230
475 BACK PAIN 5352 0.0230
476 LIP SWELLING 766 0.0230
477 FOOT FRACTURE 436 0.0230
478 INFLUENZA 2564 0.0230
479 SPINAL COMPRESSION FRACTURE 190 0.0230
480 MYOPATHY 198 0.0229
481 PHOTOPHOBIA 431 0.0229
482 ASPARTATE AMINOTRANSFERASE INCREASED 1217 0.0229
483 CEREBRAL DISORDER 169 0.0228
484 EPISTAXIS 1706 0.0228
485 PYELONEPHRITIS 197 0.0227
486 CHROMATURIA 513 0.0227
487 PRODUCT AVAILABILITY ISSUE 516 0.0226
488 LOCALISED INFECTION 548 0.0226
489 TACHYCARDIA 2013 0.0226
490 PAIN IN EXTREMITY 6668 0.0226
491 ABASIA 559 0.0226
492 CONFUSIONAL STATE 3652 0.0226
493 INFLAMMATION 1166 0.0226
494 HYDRONEPHROSIS 169 0.0226
495 WOUND 630 0.0225
496 TOXIC EPIDERMAL NECROLYSIS 342 0.0225
497 BLOOD DISORDER 180 0.0224
498 URINARY TRACT INFECTION 3825 0.0224
499 DRUG ERUPTION 397 0.0224
500 NECK PAIN 1252 0.0224
501 EMBOLISM 186 0.0224
502 DERMATITIS BULLOUS 162 0.0224
503 FOOT DEFORMITY 248 0.0224
504 LUNG DISORDER 1093 0.0223
505 COLD SWEAT 392 0.0222
506 COMA 1059 0.0222
507 TEMPERATURE INTOLERANCE 229 0.0222
508 PHARYNGITIS 275 0.0221
509 FLATULENCE 1257 0.0221
510 SECRETION DISCHARGE 277 0.0221
511 ACIDOSIS 169 0.0221
512 WRIST FRACTURE 264 0.0220
513 MUSCLE ATROPHY 279 0.0220
514 CARDIOVASCULAR DISORDER 559 0.0220
515 ANAL INCONTINENCE 198 0.0220
516 VITAMIN D DECREASED 188 0.0220
517 COVID-19 3858 0.0220
518 FACE OEDEMA 370 0.0219
519 WRONG TECHNIQUE IN DRUG USAGE PROCESS 796 0.0219
520 ERUCTATION 423 0.0218
521 MIDDLE INSOMNIA 407 0.0218
522 INITIAL INSOMNIA 223 0.0217
523 MYOSITIS 195 0.0217
524 PURPURA 192 0.0217
525 DYSPHAGIA 2059 0.0217
526 GASTROINTESTINAL HAEMORRHAGE 1812 0.0217
527 SWELLING FACE 1411 0.0216
528 PNEUMONIA 7014 0.0216
529 BLOOD ALKALINE PHOSPHATASE INCREASED 538 0.0216
530 LOWER LIMB FRACTURE 416 0.0216
531 MALIGNANT MELANOMA 290 0.0216
532 TENDON RUPTURE 267 0.0216
533 KIDNEY INFECTION 424 0.0216
534 ASTHMA 2441 0.0216
535 DISORIENTATION 850 0.0214
536 DRY MOUTH 1738 0.0214
537 BOWEL MOVEMENT IRREGULARITY 164 0.0214
538 BLINDNESS UNILATERAL 302 0.0214
539 BONE DISORDER 390 0.0214
540 JAUNDICE 572 0.0212
541 AGRANULOCYTOSIS 395 0.0212
542 INSOMNIA 5649 0.0212
543 FEELING COLD 589 0.0211
544 OSTEOPOROSIS 869 0.0211
545 TACHYPNOEA 287 0.0211
546 APHTHOUS ULCER 163 0.0210
547 FREQUENT BOWEL MOVEMENTS 567 0.0210
548 THROAT IRRITATION 941 0.0210
549 MUSCULOSKELETAL PAIN 1097 0.0209
550 HYPERSOMNIA 597 0.0208
551 ALANINE AMINOTRANSFERASE INCREASED 1278 0.0208
552 HEPATOCELLULAR INJURY 295 0.0208
553 ABDOMINAL DISCOMFORT 3484 0.0207
554 COVID-19 PNEUMONIA 245 0.0207
555 MYASTHENIA GRAVIS 167 0.0207
556 SINUSITIS 2119 0.0207
557 SOMNOLENCE 4163 0.0207
558 LETHARGY 1189 0.0206
559 HERNIA 399 0.0206
560 RETINAL DETACHMENT 189 0.0205
561 FLUID OVERLOAD 299 0.0205
562 PARALYSIS 294 0.0205
563 CELLULITIS 1032 0.0205
564 COAGULOPATHY 341 0.0204
565 ABDOMINAL DISTENSION 2129 0.0204
566 NEPHROLITHIASIS 935 0.0204
567 SCRATCH 215 0.0204
568 DEPRESSED MOOD 1076 0.0203
569 VISION BLURRED 2790 0.0203
570 OESOPHAGITIS 221 0.0202
571 FEMUR FRACTURE 626 0.0202
572 MULTI-ORGAN FAILURE 348 0.0201
573 PLATELET COUNT INCREASED 262 0.0201
574 PHARYNGEAL OEDEMA 309 0.0201
575 FACIAL PARALYSIS 171 0.0200
576 OROPHARYNGEAL PAIN 1856 0.0200
577 HAEMOPTYSIS 558 0.0200
578 INTERNAL HAEMORRHAGE 228 0.0199
579 FEELING HOT 1221 0.0199
580 HICCUPS 163 0.0198
581 LOCAL SWELLING 346 0.0198
582 GASTROENTERITIS VIRAL 358 0.0198
583 BRAIN NEOPLASM 182 0.0198
584 KNEE ARTHROPLASTY 416 0.0197
585 THROMBOSIS 1587 0.0197
586 LIVER DISORDER 874 0.0197
587 TENDERNESS 205 0.0197
588 NEOPLASM MALIGNANT 1312 0.0196
589 PULMONARY THROMBOSIS 214 0.0196
590 NEURALGIA 477 0.0196
591 NERVE INJURY 218 0.0196
592 ABDOMINAL PAIN UPPER 4035 0.0196
593 ECONOMIC PROBLEM 297 0.0196
594 PSYCHOLOGICAL TRAUMA 169 0.0196
595 BLOOD THYROID STIMULATING HORMONE INCREASED 180 0.0195
596 HYPOAESTHESIA 2927 0.0195
597 HEPATOMEGALY 192 0.0195
598 METASTASES TO LIVER 342 0.0194
599 ABDOMINAL PAIN 4526 0.0194
600 WHITE BLOOD CELL COUNT INCREASED 746 0.0194
601 EYE PAIN 1097 0.0194
602 HYPERHIDROSIS 2504 0.0194
603 ARTHRALGIA 8080 0.0194
604 HEPATIC CIRRHOSIS 365 0.0194
605 RESPIRATORY DISORDER 581 0.0194
606 MUSCLE TIGHTNESS 314 0.0194
607 GASTRIC HAEMORRHAGE 223 0.0194
608 SINUS TACHYCARDIA 275 0.0193
609 LUNG INFILTRATION 171 0.0193
610 MOBILITY DECREASED 1388 0.0193
611 RESPIRATORY TRACT INFECTION 503 0.0193
612 ROAD TRAFFIC ACCIDENT 806 0.0192
613 THERAPEUTIC RESPONSE UNEXPECTED 864 0.0192
614 TOOTH ABSCESS 196 0.0192
615 NEUTROPHIL COUNT INCREASED 197 0.0192
616 VIRAL INFECTION 640 0.0192
617 DRUG LEVEL INCREASED 318 0.0192
618 COLITIS 727 0.0192
619 SQUAMOUS CELL CARCINOMA 180 0.0191
620 HEPATIC FUNCTION ABNORMAL 713 0.0191
621 MUSCLE SPASMS 3503 0.0191
622 PHOTOSENSITIVITY REACTION 315 0.0191
623 FRACTURE 361 0.0191
624 HEPATIC ENZYME INCREASED 1300 0.0191
625 APATHY 278 0.0190
626 ACUTE RESPIRATORY FAILURE 366 0.0190
627 RASH MACULO-PAPULAR 423 0.0190
628 DELIRIUM 659 0.0190
629 FLUSHING 1930 0.0190
630 CLOSTRIDIUM DIFFICILE COLITIS 201 0.0189
631 INCREASED APPETITE 362 0.0189
632 GALLBLADDER DISORDER 337 0.0189
633 SEPSIS 2105 0.0189
634 DYSGEUSIA 1402 0.0189
635 EYE DISORDER 620 0.0188
636 BLOOD TEST ABNORMAL 264 0.0188
637 DIARRHOEA 12122 0.0188
638 BLADDER DISORDER 186 0.0187
639 HYPERSENSITIVITY 3471 0.0187
640 RESPIRATORY FAILURE 1350 0.0185
641 MYOCARDITIS 212 0.0185
642 VISUAL ACUITY REDUCED 614 0.0185
643 LOWER RESPIRATORY TRACT INFECTION 839 0.0184
644 HEPATITIS 472 0.0184
645 VITREOUS FLOATERS 181 0.0184
646 PNEUMONIA BACTERIAL 169 0.0184
647 OSTEOPENIA 279 0.0184
648 GINGIVAL BLEEDING 251 0.0184
649 GASTROINTESTINAL PAIN 202 0.0183
650 LIVER FUNCTION TEST ABNORMAL 533 0.0183
651 SEPTIC SHOCK 797 0.0183
652 PALLOR 497 0.0182
653 CONSTIPATION 3943 0.0181
654 HYPOXIA 634 0.0180
655 HYPOAESTHESIA ORAL 271 0.0180
656 DIALYSIS 255 0.0180
657 ELECTROCARDIOGRAM QT PROLONGED 646 0.0179
658 RASH PRURITIC 971 0.0179
659 HEADACHE 11208 0.0179
660 SPINAL FRACTURE 358 0.0178
661 LEUKOCYTOSIS 323 0.0178
662 PETECHIAE 186 0.0178
663 PROCEDURAL PAIN 494 0.0178
664 PNEUMONIA ASPIRATION 444 0.0178
665 CHILLS 2076 0.0177
666 POST PROCEDURAL COMPLICATION 340 0.0177
667 PRURITUS 6803 0.0177
668 LEUKAEMIA 167 0.0177
669 VASCULITIS 206 0.0177
670 BURNING SENSATION 1235 0.0176
671 ANXIETY 5011 0.0176
672 EAR PAIN 342 0.0176
673 SPLENOMEGALY 206 0.0176
674 ORAL PAIN 393 0.0175
675 LYMPHOCYTE COUNT DECREASED 310 0.0175
676 MASS 245 0.0175
677 DEPRESSED LEVEL OF CONSCIOUSNESS 693 0.0175
678 AGEUSIA 436 0.0175
679 DEPRESSION 3969 0.0174
680 HYPOPHAGIA 445 0.0174
681 RESTLESSNESS 637 0.0174
682 BLOOD BILIRUBIN INCREASED 470 0.0174
683 DISCOMFORT 1058 0.0173
684 DRUG-INDUCED LIVER INJURY 544 0.0173
685 PANCREATITIS 914 0.0173
686 UNDERDOSE 1262 0.0173
687 HYPOTONIA 172 0.0172
688 MUSCULOSKELETAL STIFFNESS 1505 0.0172
689 TOOTH FRACTURE 188 0.0170
690 RETCHING 363 0.0170
691 NEPHROPATHY TOXIC 191 0.0170
692 SCAR 290 0.0169
693 LUNG INFECTION 262 0.0168
694 TASTE DISORDER 342 0.0168
695 OSTEOMYELITIS 305 0.0168
696 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1197 0.0168
697 UPPER RESPIRATORY TRACT INFECTION 777 0.0168
698 PRODUCT DOSE OMISSION IN ERROR 476 0.0168
699 GASTROINTESTINAL DISORDER 1504 0.0168
700 BREAST PAIN 179 0.0168
701 SKIN DISCOLOURATION 771 0.0168
702 EYELID OEDEMA 195 0.0168
703 SKIN CANCER 360 0.0167
704 VAGINAL DISCHARGE 169 0.0167
705 DEATH 14387 0.0167
706 ABDOMINAL PAIN LOWER 421 0.0166
707 WOUND INFECTION 182 0.0166
708 NEOPLASM 191 0.0166
709 INTRAOCULAR PRESSURE INCREASED 212 0.0166
710 HERPES ZOSTER 951 0.0165
711 LACRIMATION INCREASED 499 0.0165
712 TENDONITIS 255 0.0165
713 BRONCHOSPASM 235 0.0165
714 FIBROMYALGIA 399 0.0164
715 HOT FLUSH 1235 0.0164
716 MULTIPLE ORGAN DYSFUNCTION SYNDROME 464 0.0164
717 ILL-DEFINED DISORDER 995 0.0164
718 TREMOR 2709 0.0163
719 ADRENAL INSUFFICIENCY 198 0.0163
720 SKIN LESION 447 0.0163
721 FEELING JITTERY 310 0.0163
722 RESPIRATORY DISTRESS 448 0.0162
723 HAIR COLOUR CHANGES 202 0.0162
724 PARAESTHESIA 2553 0.0162
725 RESTLESS LEGS SYNDROME 295 0.0162
726 NAUSEA 12834 0.0162
727 NEUROPATHY PERIPHERAL 1540 0.0162
728 IRRITABLE BOWEL SYNDROME 347 0.0162
729 VOMITING 7605 0.0162
730 TOOTHACHE 291 0.0161
731 LYMPHOMA 248 0.0160
732 UNRESPONSIVE TO STIMULI 414 0.0160
733 BLISTER 899 0.0160
734 DISTURBANCE IN ATTENTION 861 0.0159
735 SARS-COV-2 TEST POSITIVE 210 0.0159
736 TOOTH INFECTION 209 0.0158
737 BONE PAIN 928 0.0158
738 NIGHT SWEATS 510 0.0158
739 FEEDING DISORDER 321 0.0158
740 JOINT STIFFNESS 415 0.0158
741 PRODUCT USE IN UNAPPROVED INDICATION 3920 0.0158
742 POST PROCEDURAL HAEMORRHAGE 184 0.0158
743 PYREXIA 5452 0.0157
744 PRODUCT DOSE OMISSION ISSUE 4607 0.0157
745 SKIN REACTION 220 0.0156
746 ILEUS 194 0.0156
747 JOINT RANGE OF MOTION DECREASED 209 0.0156
748 HUNGER 216 0.0155
749 SCAB 176 0.0154
750 SKIN INFECTION 173 0.0154
751 METASTASES TO BONE 252 0.0153
752 PANCYTOPENIA 857 0.0153
753 IMPAIRED GASTRIC EMPTYING 209 0.0153
754 PNEUMOTHORAX 243 0.0153
755 MYELODYSPLASTIC SYNDROME 221 0.0153
756 COGNITIVE DISORDER 713 0.0153
757 PULMONARY EMBOLISM 1450 0.0152
758 NODULE 199 0.0152
759 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 731 0.0152
760 RHEUMATOID ARTHRITIS 1723 0.0152
761 PNEUMONITIS 412 0.0151
762 ORAL DISCOMFORT 210 0.0151
763 HALLUCINATION, VISUAL 319 0.0151
764 ENCEPHALOPATHY 370 0.0151
765 TOOTH DISORDER 334 0.0150
766 BACTERIAL INFECTION 280 0.0150
767 BODY TEMPERATURE INCREASED 305 0.0149
768 PLATELET COUNT DECREASED 1587 0.0149
769 LYMPHADENOPATHY 524 0.0148
770 PAIN 9078 0.0148
771 EYE SWELLING 549 0.0147
772 CYST 183 0.0147
773 LUNG NEOPLASM MALIGNANT 606 0.0147
774 ANHEDONIA 386 0.0147
775 IMPAIRED QUALITY OF LIFE 211 0.0147
776 IMPAIRED HEALING 481 0.0146
777 MEDICATION ERROR 813 0.0146
778 PRODUCT SUBSTITUTION ISSUE 842 0.0146
779 PAIN IN JAW 414 0.0146
780 INFUSION RELATED REACTION 967 0.0146
781 DIABETIC KETOACIDOSIS 350 0.0146
782 RESPIRATORY ARREST 401 0.0145
783 FUNGAL INFECTION 484 0.0145
784 MYOCLONUS 173 0.0145
785 PANIC ATTACK 527 0.0144
786 EYE INFECTION 163 0.0144
787 GASTRIC DISORDER 495 0.0144
788 MENTAL IMPAIRMENT 348 0.0143
789 MUSCLE RIGIDITY 170 0.0142
790 BEDRIDDEN 186 0.0141
791 THROMBOCYTOPENIA 1581 0.0141
792 MENTAL STATUS CHANGES 391 0.0141
793 THROAT TIGHTNESS 380 0.0140
794 BLOOD COUNT ABNORMAL 213 0.0140
795 SMALL INTESTINAL OBSTRUCTION 172 0.0140
796 SKIN DISORDER 466 0.0140
797 ERYTHEMA 2868 0.0139
798 LIVER FUNCTION TEST INCREASED 299 0.0139
799 RASH MACULAR 484 0.0138
800 DEEP VEIN THROMBOSIS 899 0.0138
801 PERITONITIS 286 0.0138
802 NIGHTMARE 477 0.0138
803 INFLUENZA LIKE ILLNESS 1128 0.0137
804 HEPATIC FAILURE 413 0.0137
805 HAIR TEXTURE ABNORMAL 183 0.0137
806 CYANOSIS 215 0.0137
807 ORAL HERPES 266 0.0136
808 CANDIDA INFECTION 230 0.0136
809 SUICIDE ATTEMPT 825 0.0136
810 RASH ERYTHEMATOUS 648 0.0135
811 MENTAL DISORDER 589 0.0135
812 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 348 0.0135
813 THINKING ABNORMAL 252 0.0135
814 IMMUNODEFICIENCY 201 0.0135
815 RASH 5876 0.0135
816 ABSCESS 215 0.0135
817 BRAIN FOG 210 0.0134
818 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 952 0.0134
819 HAEMORRHAGE INTRACRANIAL 200 0.0134
820 DRUG DISPENSING ERROR 204 0.0133
821 PANCREATIC CARCINOMA 385 0.0133
822 CONDITION AGGRAVATED 4052 0.0133
823 INJURY 934 0.0133
824 DISSEMINATED INTRAVASCULAR COAGULATION 187 0.0133
825 LIVER INJURY 326 0.0133
826 FULL BLOOD COUNT DECREASED 267 0.0132
827 HAEMORRHAGE 1385 0.0132
828 EAR INFECTION 352 0.0132
829 ACTIVITIES OF DAILY LIVING IMPAIRED 261 0.0132
830 RASH GENERALISED 338 0.0130
831 TRANSAMINASES INCREASED 290 0.0130
832 INTESTINAL OBSTRUCTION 490 0.0130
833 AGITATION 949 0.0129
834 RASH PAPULAR 288 0.0128
835 ACUTE RESPIRATORY DISTRESS SYNDROME 227 0.0128
836 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 298 0.0128
837 ALOPECIA 2496 0.0127
838 SENSORY DISTURBANCE 202 0.0126
839 HALLUCINATION 944 0.0125
840 TREATMENT NONCOMPLIANCE 685 0.0125
841 PSORIASIS 1630 0.0125
842 STOMATITIS 755 0.0124
843 PRODUCT DISPENSING ERROR 271 0.0124
844 INFECTION 1792 0.0124
845 STAPHYLOCOCCAL INFECTION 408 0.0124
846 ANOSMIA 179 0.0124
847 EMOTIONAL DISORDER 381 0.0123
848 GLOSSODYNIA 275 0.0123
849 ECZEMA 639 0.0122
850 LABORATORY TEST ABNORMAL 360 0.0122
851 DYSKINESIA 494 0.0121
852 CLOSTRIDIUM DIFFICILE INFECTION 265 0.0121
853 DRY EYE 605 0.0121
854 WHITE BLOOD CELL COUNT DECREASED 1312 0.0121
855 SKIN EXFOLIATION 1020 0.0121
856 PHARMACEUTICAL PRODUCT COMPLAINT 311 0.0120
857 URTICARIA 2005 0.0120
858 MOUTH ULCERATION 252 0.0119
859 DERMATITIS 247 0.0118
860 EYE PRURITUS 395 0.0117
861 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 199 0.0117
862 LYMPHOPENIA 165 0.0117
863 INTENTIONAL OVERDOSE 743 0.0116
864 MUCOSAL INFLAMMATION 301 0.0115
865 MUSCULOSKELETAL DISORDER 217 0.0114
866 DELUSION 177 0.0114
867 INTENTIONAL PRODUCT USE ISSUE 997 0.0114
868 DEVICE RELATED INFECTION 175 0.0114
869 PRODUCT USE ISSUE 2131 0.0113
870 ABNORMAL DREAMS 313 0.0113
871 OCULAR HYPERAEMIA 537 0.0113
872 COLITIS ULCERATIVE 505 0.0113
873 ANAPHYLACTIC SHOCK 291 0.0113
874 INTENTIONAL DOSE OMISSION 319 0.0112
875 LEUKOPENIA 558 0.0111
876 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 191 0.0111
877 INCORRECT DOSE ADMINISTERED 2537 0.0111
878 SURGERY 649 0.0111
879 STEVENS-JOHNSON SYNDROME 246 0.0111
880 PSYCHOMOTOR HYPERACTIVITY 183 0.0110
881 CONVULSION 630 0.0110
882 DRUG EFFECT LESS THAN EXPECTED 163 0.0110
883 NO ADVERSE EVENT 1976 0.0109
884 FEBRILE NEUTROPENIA 723 0.0109
885 DRUG INEFFECTIVE 14327 0.0109
886 PERICARDITIS 182 0.0108
887 HIP ARTHROPLASTY 164 0.0107
888 ANAPHYLACTIC REACTION 589 0.0106
889 MULTIPLE FRACTURES 174 0.0106
890 CONJUNCTIVITIS 195 0.0105
891 PRODUCT PHYSICAL ISSUE 210 0.0104
892 HEPATIC CANCER 250 0.0104
893 CRYING 378 0.0104
894 OSTEONECROSIS OF JAW 257 0.0104
895 GASTRIC CANCER 261 0.0103
896 UNEVALUABLE EVENT 779 0.0103
897 NEUTROPHIL COUNT DECREASED 418 0.0102
898 MOOD ALTERED 278 0.0102
899 EYE IRRITATION 585 0.0102
900 OFF LABEL USE 8814 0.0101
901 THERAPEUTIC RESPONSE DECREASED 608 0.0100
902 PSORIATIC ARTHROPATHY 407 0.0100
903 MIGRAINE 949 0.0099
904 INTENTIONAL PRODUCT MISUSE 847 0.0097
905 BREAST CANCER 898 0.0096
906 NERVOUS SYSTEM DISORDER 300 0.0096
907 PROSTATE CANCER 772 0.0096
908 DISEASE RECURRENCE 456 0.0096
909 ANGER 323 0.0095
910 DRUG ADMINISTRATION ERROR 293 0.0095
911 IMPAIRED WORK ABILITY 203 0.0095
912 IRRITABILITY 564 0.0094
913 DRY SKIN 1235 0.0092
914 THERAPEUTIC PRODUCT EFFECT DECREASED 413 0.0092
915 EPILEPSY 280 0.0092
916 SKIN FISSURES 179 0.0091
917 SYSTEMIC LUPUS ERYTHEMATOSUS 323 0.0091
918 MUSCLE TWITCHING 209 0.0091
919 PRESCRIBED OVERDOSE 175 0.0090
920 HEPATOTOXICITY 200 0.0090
921 EMOTIONAL DISTRESS 1078 0.0089
922 PLASMA CELL MYELOMA 342 0.0088
923 NEUTROPENIA 1191 0.0088
924 THERAPY NON-RESPONDER 392 0.0087
925 TOXICITY TO VARIOUS AGENTS 1468 0.0087
926 TOOTH LOSS 177 0.0085
927 ADVERSE DRUG REACTION 762 0.0085
928 CYTOKINE RELEASE SYNDROME 164 0.0082
929 DRUG EFFECT DECREASED 434 0.0080
930 ACCIDENTAL OVERDOSE 294 0.0080
931 OSTEONECROSIS 259 0.0079
932 RENAL CANCER 375 0.0079
933 INTENTIONAL DRUG MISUSE 164 0.0078
934 PRODUCT DOSE OMISSION 511 0.0078
935 SEIZURE 895 0.0077
936 PRODUCT PRESCRIBING ISSUE 168 0.0077
937 DEVICE MALFUNCTION 540 0.0077
938 NEOPLASM PROGRESSION 263 0.0076
939 DISEASE PROGRESSION 890 0.0075
940 AGGRESSION 375 0.0075
941 EXPIRED PRODUCT ADMINISTERED 247 0.0074
942 MALIGNANT NEOPLASM PROGRESSION 759 0.0074
943 ADVERSE EVENT 669 0.0073
944 PRODUCT QUALITY ISSUE 985 0.0072
945 OVERDOSE 1561 0.0072
946 THERAPY CESSATION 367 0.0071
947 SUICIDAL IDEATION 627 0.0068
948 ABNORMAL BEHAVIOUR 267 0.0067
949 SEDATION 175 0.0067
950 PREMATURE BABY 198 0.0066
951 THERAPEUTIC RESPONSE SHORTENED 217 0.0065
952 DRUG DOSE OMISSION 1081 0.0065
953 THERAPY INTERRUPTED 464 0.0065
954 EXTRA DOSE ADMINISTERED 262 0.0065
955 INJECTION SITE HAEMORRHAGE 512 0.0064
956 NEEDLE ISSUE 185 0.0063
957 INJECTION SITE MASS 235 0.0063
958 PAIN OF SKIN 171 0.0063
959 TREATMENT FAILURE 525 0.0063
960 BREAST CANCER FEMALE 168 0.0063
961 BLADDER CANCER 370 0.0063
962 DRUG EFFECT INCOMPLETE 226 0.0062
963 MOOD SWINGS 197 0.0062
964 INCORRECT DRUG ADMINISTRATION DURATION 167 0.0059
965 PSYCHOTIC DISORDER 175 0.0059
966 MULTIPLE SCLEROSIS 280 0.0058
967 INJECTION SITE PRURITUS 380 0.0057
968 INJECTION SITE BRUISING 443 0.0055
969 FOETAL EXPOSURE DURING PREGNANCY 451 0.0055
970 HOSPITALISATION 851 0.0055
971 BONE DENSITY DECREASED 173 0.0055
972 WITHDRAWAL SYNDROME 225 0.0054
973 VAGINAL HAEMORRHAGE 230 0.0053
974 SKIN IRRITATION 239 0.0052
975 ACNE 393 0.0052
976 INJECTION SITE ERYTHEMA 636 0.0051
977 SKIN BURNING SENSATION 364 0.0051
978 INJECTION SITE PAIN 1556 0.0051
979 DRUG ABUSE 395 0.0047
980 MATERNAL EXPOSURE DURING PREGNANCY 405 0.0045
981 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 249 0.0045
982 COLORECTAL CANCER 214 0.0045
983 INJECTION SITE SWELLING 334 0.0044
984 MULTIPLE SCLEROSIS RELAPSE 290 0.0042
985 COMPLETED SUICIDE 332 0.0040
986 INJECTION SITE REACTION 253 0.0037
987 EXPOSURE DURING PREGNANCY 224 0.0036
988 DERMATITIS ATOPIC 181 0.0034
989 DRUG WITHDRAWAL SYNDROME 291 0.0033
990 DEVICE ISSUE 284 0.0032
991 ACCIDENTAL EXPOSURE TO PRODUCT 272 0.0026
992 PRODUCT STORAGE ERROR 204 0.0023
993 DRUG DEPENDENCE 317 0.0020